Interviews
Quick-Med to present NIMBUS at SAWC/WHS
10 Apr '09
3 min read
Quick-Med Technologies, Inc. an emerging life sciences company specializing in novel antimicrobial technologies, announced that data on three of its proprietary antimicrobial technologies is being presented at the 2009 Symposium on Advanced Wound Care and the Wound Healing Society meeting. This event is the premier annual meeting of physicians, researchers and other wound care specialists and is being held in Dallas, Texas, on April 26-29, 2009. Quick-Med's scientists will present four abstracts at the prestigious meeting.
Two of Quick-Med's abstracts feature key aspects of the company's NIMBUS Barrier Gauze Dressing, a unique, non-leaching antimicrobial technology that recently received FDA clearance:
Antimicrobial Wound Dressings: Mechanisms and Function – A profile of the barrier properties of NIMBUS that substantiates its performance in the presence of wound exudate while permitting safe and rapid healing without risk of bacterial mutation. It is a predicate material ready for incorporation into other application formats.
Bacterial Resistance Issues in Wound Care and Wound Dressings – A review of the basic process that leads to the development of bacterial resistance by various microbicidal materials and a summary of the test results demonstrating that NIMBUS does not display this mutation effect.
NIMBUS offers improved safety and efficacy. It is unique in that it is a sterile bacterial barrier that prohibits the transfer of microorganisms into the wound because the microbicidal agent is irreversibly bound to the dressing.
“NIMBUS is the first bound, antimicrobial material – rather than delivering an antimicrobial into the wound, it creates a barrier that won't allow bacteria to penetrate the dressing or grow in the wound fluid,” says Gregory Schultz, Professor, Institute for Wound Research at the University of Florida and Past President of the Wound Healing Society. “Traditional wound dressings absorb fluid from the wound and act as a great incubator for bacteria that are shed back into the wound.”
NIMBUS is non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration. Product labeling has been allowed that indicates various organisms such as MRSA, VRE, Pseudomonas aeruginosa and Escherichia coli are killed at levels exceeding 99.999%. NIMBUS barrier gauze will be available in June under license from Quick-Med and will be marketed as BIOGUARD by Derma Sciences.
Additional Technologies
Additionally, Quick-Med posters will present data on NimbuDerm, the company's persistent hand sanitizer technology, and Stay Fresh, a new highly durable textiles technology that is especially well suited for health care applications:
Hand Sanitizer Technology and Progress Toward a more Functional Concept – Achievement of sustained antimicrobial protection exceeding six hours via the development of a high performance, breathable skin sanitizer coating which is a barrier to adventitious contamination.
Two of Quick-Med's abstracts feature key aspects of the company's NIMBUS Barrier Gauze Dressing, a unique, non-leaching antimicrobial technology that recently received FDA clearance:
Antimicrobial Wound Dressings: Mechanisms and Function – A profile of the barrier properties of NIMBUS that substantiates its performance in the presence of wound exudate while permitting safe and rapid healing without risk of bacterial mutation. It is a predicate material ready for incorporation into other application formats.
Bacterial Resistance Issues in Wound Care and Wound Dressings – A review of the basic process that leads to the development of bacterial resistance by various microbicidal materials and a summary of the test results demonstrating that NIMBUS does not display this mutation effect.
NIMBUS offers improved safety and efficacy. It is unique in that it is a sterile bacterial barrier that prohibits the transfer of microorganisms into the wound because the microbicidal agent is irreversibly bound to the dressing.
“NIMBUS is the first bound, antimicrobial material – rather than delivering an antimicrobial into the wound, it creates a barrier that won't allow bacteria to penetrate the dressing or grow in the wound fluid,” says Gregory Schultz, Professor, Institute for Wound Research at the University of Florida and Past President of the Wound Healing Society. “Traditional wound dressings absorb fluid from the wound and act as a great incubator for bacteria that are shed back into the wound.”
NIMBUS is non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration. Product labeling has been allowed that indicates various organisms such as MRSA, VRE, Pseudomonas aeruginosa and Escherichia coli are killed at levels exceeding 99.999%. NIMBUS barrier gauze will be available in June under license from Quick-Med and will be marketed as BIOGUARD by Derma Sciences.
Additional Technologies
Additionally, Quick-Med posters will present data on NimbuDerm, the company's persistent hand sanitizer technology, and Stay Fresh, a new highly durable textiles technology that is especially well suited for health care applications:
Hand Sanitizer Technology and Progress Toward a more Functional Concept – Achievement of sustained antimicrobial protection exceeding six hours via the development of a high performance, breathable skin sanitizer coating which is a barrier to adventitious contamination.
Popular News
Leave your Comments
Editor’s Pick
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
